BU-LAD
From Wikipedia, the free encyclopedia
 |
|
 |
|
|
BU-LAD
|
|
| Systematic (IUPAC) name | |
| (6aR,9R)-N,N-diethyl-7-butyl-4,6,6a,7,8,9- hexahydroindolo-[4,3-fg]quinoline-9-carboxamide |
|
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C23H31N3O |
| Mol. mass | 365.52 g/mol |
| Synonyms | BU-LAD, 6-butyl-6-nor-Lysergic acid diethylamide |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | hepatic |
| Half life | ? |
| Excretion | renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Controlled in the US via the Federal Analog Act |
| Routes | Oral |
BU-LAD, also known as 6-butyl-6-nor-lysergic acid diethylamide, is an analogue of LSD first made by Alexander Shulgin and reported in the book TiHKAL. BU-LAD is a hallucinogenic drug similar to LSD, but is significantly less potent than LSD with a dose of 500 micrograms producing only mild effects.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||
